BeOne Medicines (ONC) Short Interest Ratio & Short Volume

Short interest is the volume of BeOne Medicines shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 1,490,000 shares of ONC short. 1.37% of BeOne Medicines' shares are currently sold short. Learn More on BeOne Medicines' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONC shares currently have a short interest ratio of 4.0. Learn More on BeOne Medicines's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BeOne Medicines: Group One Trading LLC, Jane Street Group LLC, Caption Management LLC, JPMorgan Chase & Co., Simplex Trading LLC, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.37% of BeOne Medicines' floating shares are currently sold short.

BeOne Medicines saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 1,490,000 shares, a drop of 5.1% from the previous total of 1,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

BeOne Medicines currently has issued a total of 109,600,000 shares. Some of BeOne Medicines' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BeOne Medicines currently has a public float of 108,760,000 shares.

1.37% of BeOne Medicines' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BeOne Medicines: Sanofi (0.21%), GSK PLC Sponsored ADR (0.55%), Takeda Pharmaceutical Co. (0.25%), argenex SE (3.01%), Insmed, Inc. (5.15%), BioNTech SE Sponsored ADR (2.54%), Teva Pharmaceutical Industries Ltd. (4.43%), Summit Therapeutics PLC (26.50%), Genmab A/S Sponsored ADR (0.63%), Ascendis Pharma A/S (7.30%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling ONC is an investing strategy that aims to generate trading profit from BeOne Medicines as its price is falling. ONC shares are trading down $11.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BeOne Medicines occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONC, twice per month. The most recent reporting period available is August, 31 2025.